Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
3,415,938
-
Shares change
-
-1,066,410
-
Total reported value, excl. options
-
$10,142,998
-
Value change
-
-$3,226,983
-
Number of buys
-
26
-
Number of sells
-
-36
-
Price
-
$2.97
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q2 2025
69 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q2 2025.
XBiotech Inc. - Common Shares, no par value (XBIT) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,415,938 shares
of 33,289,095 outstanding shares and own 10.26% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (945,405 shares), MILLENNIUM MANAGEMENT LLC (551,347 shares), BlackRock, Inc. (373,606 shares), GEODE CAPITAL MANAGEMENT, LLC (220,679 shares), RBF Capital, LLC (200,000 shares), GOLDMAN SACHS GROUP INC (112,084 shares), NORTHERN TRUST CORP (93,155 shares), MORGAN STANLEY (85,805 shares), DIMENSIONAL FUND ADVISORS LP (70,965 shares), and STATE STREET CORP (68,526 shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.